{"abstract": "Zentiva, the Czech drug company, agreed Monday to be acquired by Sanofi-Aventis after Sanofi raised its bid. The new deal, valued at $2.6 billion, will give Zentiva shareholders $69.71 per share in what amounts to a 9.5 percent increase on the original offer, which Zentiva had rejected.", "web_url": "https://dealbook.nytimes.com/2008/09/22/sanofi-raises-zentiva-offer-to-win-board-support/", "snippet": "", "lead_paragraph": "Zentiva, the Czech drug company, agreed Monday to be acquired by Sanofi-Aventis after Sanofi raised its bid. The new deal, valued at $2.6 billion, will give Zentiva shareholders $69.71 per share in what amounts to a 9.5 percent increase on the original offer, which Zentiva had rejected.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Sanofi Raises Zentiva Offer to Win Board Support", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-09-22T11:36:01+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/4e41daa3-99ec-58df-bf96-dc1fd4fe7b87", "word_count": 106, "uri": "nyt://article/4e41daa3-99ec-58df-bf96-dc1fd4fe7b87"}